Walleye Trading LLC Kura Oncology, Inc. Call Options Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$17.53 - $22.98 $84,144 - $110,304	4,800 Added 218.18%	7,000 $144,000
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $29,524 - $51,766	2,200 New	2,200 $46,000
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $37,231 - $60,295	3,100 New	3,100 $42,000
Q1 2021 May 17, 2021	SELL	$24.75 - $39.14 $492,525 - $778,886	-19,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $577,100 - $828,238	19,900 New	19,900 $650,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.